Experiments for taxon Dracaena angustifolia (AGAVACEAE)

Experiments (82 results)

Filters
Worktypes (13)
48
18
10
10
10
10
8
8
6
4
2
2
2
No match
Pharmacology (11)
50
4
1
1
1
1
1
1
1
1
20
No match
Compounds (19)
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
16
No match
Organisms (4)
69
5
4
4
No match
82 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
283144
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN D
283133
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN A
487833
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283182
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283147
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN E
283125
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(S):
283136
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN B
283160
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-24-O-BETA-D-FUCOPYRANOSIDE
283122
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(S):NAMOGENIN A,25(R):
283132
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN A
1154401
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Dracaena angustifolia (AGAVACEAE)
548199
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
ANTIMALARIAL ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283166
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]}-ALPHA-L-ARABINOPYRANOSIDE
283171
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
FUROSTA-5-20(22)-25(27)-TRIEN-1-BETA-3-BETA-26-TRIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-26-O-BETA-D-GLUCOPYRANOSIDE
283177
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-ALPHA-L-ARABINOPYRANOSIDE
283158
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE}-24-O-BETA-D-FUCOPYRANOSIDE
548200
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283155
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE}-24-O-BETA-D-FUCOPYRANOSIDE
487830
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283163
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]}-ALPHA-L-ARABINOPYRANOSIDE
283126
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN B
283119
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283134
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN A
283137
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN B
283148
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN E
548197
VOUCHER SPECIMEN REPORTED FOR
Dracaena angustifolia (AGAVACEAE)
283170
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)}-ALPHA-L-ARABINOPYRANOSIDE
283145
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN D
283123
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(S):NAMOGENIN A,25(R):
283181
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283185
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
PREGNA-5-16-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283174
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
FUROSTA-5-20(22)-25(27)-TRIEN-1-BETA-3-BETA-26-TRIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-26-O-BETA-D-GLUCOPYRANOSIDE
283149
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN E
283167
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)}-ALPHA-L-ARABINOPYRANOSIDE
283159
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-24-O-BETA-D-FUCOPYRANOSIDE
283156
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE}-24-O-BETA-D-FUCOPYRANOSIDE
283130
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN C
283141
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN C
283178
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-ALPHA-L-ARABINOPYRANOSIDE
283152
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN F
283162
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-24-O-BETA-D-FUCOPYRANOSIDE
283127
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN CNAMOGENIN B
283151
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN F
1154400
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Dracaena angustifolia (AGAVACEAE)
487831
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena angustifolia (AGAVACEAE)
548201
MEDICINAL FOLKLORE REPORTED FOR
GENITOURINARY EFFECT(UNSPECIFIED)
Dracaena angustifolia (AGAVACEAE)
283142
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN C
283118
VOUCHER SPECIMEN REPORTED FOR
Dracaena angustifolia (AGAVACEAE)
283138
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN B
283180
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283164
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]}-ALPHA-L-ARABINOPYRANOSIDE
283129
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN CNAMOGENIN B
283186
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
PREGNA-5-16-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283153
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN F
283184
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
PREGNA-5-16-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283173
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
FUROSTA-5-20(22)-25(27)-TRIEN-1-BETA-3-BETA-26-TRIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-26-O-BETA-D-GLUCOPYRANOSIDE
283175
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-ALPHA-L-ARABINOPYRANOSIDE
283140
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN C
283121
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(R):
283169
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)}-ALPHA-L-ARABINOPYRANOSIDE
283124
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(S):NAMOGENIN A,25(R):
1154398
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Dracaena angustifolia (AGAVACEAE)
487832
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283146
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN D
283139
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN C
283161
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-24-O-BETA-D-FUCOPYRANOSIDE
283128
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN CNAMOGENIN B
283150
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN E
283135
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN B
283143
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN D
283179
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283154
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN F
283131
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN A
283168
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)}-ALPHA-L-ARABINOPYRANOSIDE
548198
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
COMMON COLD RELIEF
Dracaena angustifolia (AGAVACEAE)
283165
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]}-ALPHA-L-ARABINOPYRANOSIDE
283183
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
PREGNA-5-16-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283176
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-ALPHA-L-ARABINOPYRANOSIDE
283120
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283157
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE}-24-O-BETA-D-FUCOPYRANOSIDE
1154399
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283172
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
FUROSTA-5-20(22)-25(27)-TRIEN-1-BETA-3-BETA-26-TRIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-26-O-BETA-D-GLUCOPYRANOSIDE